共 127 条
[1]
Watanabe T(2013)New fecal biomarker, α1-acid glycoprotein, for evaluation of inflammatory bowel disease: comparison with calprotectin and lactoferrin Med Bull Fukuoka Univ 40 155-162
[2]
Aoyagi K(2012)Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies Inflamm Bowel Dis 18 1894-1899
[3]
Nimura S(2011)Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Gut 60 780-787
[4]
Eguchi K(2006)Laboratory markers in IBD: useful, magic, or unnecessary toys Gut 55 426-431
[5]
Tomioka Y(2008)Crohn’s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn’s disease activity index and endoscopic findings Inflamm Bowel Dis 14 40-46
[6]
Sakisaka S(2007)Review article: biological activity markers in inflammatory bowel disease Aliment Pharmacol Ther 25 247-255
[7]
Mao R(2000)Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease Gastroenterology 119 15-22
[8]
Xiao YL(2010)Comparison of fecal calprotectin level in inflammatory bowel disease and irritable bowel syndrome Govaresh 14 275-278
[9]
Gao X(2014)Calprotectin as a fecal marker for diagnosis and follow-up in patients with ulcerative colitis Menoufia Med J 27 35-43
[10]
Chen BL(2015)Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cutoffs should we apply Frontline Gastroenterol 6 14-19